Literature DB >> 18543581

Effect of aminophylline on aspirin penetration into the central nervous system in rats.

Velibor Vasović1, Branko Banić, Vida Jakovljević, Zdenko Tomic, Vukica Milic-Djordjevic.   

Abstract

This study investigated with the effect of aminophylline on the penetration of aspirin through the blood-brain barrier (BBB) into the central nervous system (CNS) in rats. Acetylsalycylic was injected into the right axillary artery, to avoid the drug affecting the peripheral organs before it reached the CNS. The test animals received subcutaneously (s.c.) aminophylline 30 min before aspirin injection, while the control animals received an equimolar dose of physiological solution s.c. At time intervals of 30, 60, 90, 120, and 240 s after aspirin injection, the animals were decapitated and blood samples from the left jugular vein, as well as samples from the brainstem, cerebellum and left and right cerebral hemispheres, were taken to determine aspirin concentrations in all of them by a standard method. It was found that aspirin concentrations in the CNS were even 30 times lower than in the blood, with the concentrations being higher in the brainstem and cerebellum than in the left and right hemispheres. The presence of aminophylline did not alter aspirin concentrations either in the blood or the brain, and therefore did not affect significantly the aspirin penetration through the BBB into the CNS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18543581     DOI: 10.1007/BF03191015

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  7 in total

1.  Fluorophotometric method for the estimation of salicylate in blood.

Authors:  A SALTZMAN
Journal:  J Biol Chem       Date:  1948-06       Impact factor: 5.157

Review 2.  Peptide transport systems for opiates across the blood-brain barrier.

Authors:  W A Banks; A J Kastin
Journal:  Am J Physiol       Date:  1990-07

3.  [Aortic arch in rodents].

Authors:  H Sinzinger; J Hohenecker
Journal:  Anat Anz       Date:  1972

4.  Permeability of the blood-brain barrier to neuropeptides: the case for penetration.

Authors:  W A Banks; A J Kastin
Journal:  Psychoneuroendocrinology       Date:  1985       Impact factor: 4.905

5.  Development of the blood-brain barrier for 6-hydroxydopamine.

Authors:  C Sachs
Journal:  J Neurochem       Date:  1973-06       Impact factor: 5.372

6.  Blood-brain barrier transport of choline is reduced in the aged rat.

Authors:  A D Mooradian
Journal:  Brain Res       Date:  1988-02-09       Impact factor: 3.252

7.  In vivo evidence for ATP-dependent and P-glycoprotein-mediated transport of cyclosporin A at the blood-brain barrier.

Authors:  A Sakata; I Tamai; K Kawazu; Y Deguchi; T Ohnishi; A Saheki; A Tsuji
Journal:  Biochem Pharmacol       Date:  1994-11-16       Impact factor: 5.858

  7 in total
  3 in total

1.  Aspirin up-regulates suppressor of cytokine signaling 3 in glial cells via PPARα.

Authors:  Sudipta Chakrabarti; Avik Roy; Tim Prorok; Dhruv Patel; Sridevi Dasarathi; Kalipada Pahan
Journal:  J Neurochem       Date:  2019-07-28       Impact factor: 5.372

2.  Efficacy of anti-inflammatory agents to improve symptoms in patients with schizophrenia: an update.

Authors:  Iris E Sommer; Roos van Westrhenen; Marieke J H Begemann; Lot D de Witte; Stefan Leucht; René S Kahn
Journal:  Schizophr Bull       Date:  2013-10-08       Impact factor: 9.306

Review 3.  An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis.

Authors:  N Çakici; N J M van Beveren; G Judge-Hundal; M M Koola; I E C Sommer
Journal:  Psychol Med       Date:  2019-08-23       Impact factor: 7.723

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.